Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices 80319 

TOTAL ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Form name Number of 

respondents 

Average 

number of 

responses per 

respondent 

Total 

number of 

responses 

Average 

burden per 

response 

(in minutes) 

Total 

burden 

hours 

Total .............................................................................................. 786 ........................ 4,242 ........................ 1,251 

a Number of respondents is based on the current number of transplant programs and is likely to increase as additional programs decide to participate. b Number of living organ donor candidates submitting follow-up forms in 2019. 

HRSA specifically requests comments 

on (1) the necessity and utility of the 

proposed information collection for the 

proper performance of the agency’s 

functions, (2) the accuracy of the 

estimated burden, (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected, and (4) the 

use of automated collection techniques 

or other forms of information 

technology to minimize the information 

collection burden. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2023–25368 Filed 11–16–23; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Announcement of Intent To Establish 

Federal Advisory Committee on Long 

COVID 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: The Department of Health and 

Human Services announces the intent to 

establish an Advisory Committee on 

Long COVID and invites nominations 

for the Committee. 

DATES: Nominations must be submitted 

by 11:59 p.m. eastern time on January 

16, 2024. 

ADDRESSES: Nominations may be 

submitted by email to LongCOVID@

hhs.gov and addressed to Allison 

O’Donnell. 202–690–7694. 

FOR FURTHER INFORMATION CONTACT: 

Allison O’Donnell at 202–690–7694 or 

LongCOVID@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Committee is authorized under 42 

U.S.C. 217a, section 222 of the Public 

Health Service Act, as amended. The 

Committee is governed by the 

provisions of the Federal Advisory 

Committee Act, Public Law 92–463, as 

amended (5 U.S.C. chapter 10), which 

sets forth standards for the formation 

and use of advisory committees. 

The April 5, 2022, Memorandum 

(https://www.whitehouse.gov/briefingroom/presidential-actions/2022/04/05/ 

memorandum-on-addressing-the-longterm-effects-of-covid-19/) on Addressing 

the Long-term Effects of COVID–19 

charged the Secretary of Health and 

Human Services (Secretary) with 

coordinating a Government-wide 

response to the longer-term effects of 

COVID–19. The Secretary named the 

Assistant Secretary for Health to 

coordinate the U.S. Government 

response to Long COVID. The 

Memorandum specified development 

and publication of two reports that were 

published August 3, 2022. One of the 

reports, the National Research Action 

Plan on Long COVID (https://

www.covid.gov/assets/files/NationalResearch-Action-Plan-on-Long-COVID08012022.pdf), called for the 

establishment of a Secretary’s Advisory 

Committee on Long COVID. The 

Committee will bring perspectives from 

outside the Government to help inform 

action of the Executive Branch on Long 

COVID and associated conditions, with 

a focus on health equity. Numerous 

entities across the U.S. Government 

fund and conduct research and use 

external advisory bodies. This Federal 

Advisory Committee does not replace or 

supersede the ongoing work of these 

advisory bodies. 

Structure: The Committee will consist 

of up to 20 members, including any 

Chair, Vice Chair, or Co-Chairs. Factors 

to be considered in selecting individuals 

to serve on the Committee include 

expertise in the issues to be examined 

by the Committee, as well as statutory 

obligations under FACA and desire for 

a balanced and diverse membership. To 

the extent possible, composition of the 

Committee will reflect the experience of 

an inclusive and diverse cross-section of 

persons with Long COVID and 

multidisciplinary expertise of those 

supporting and caring for those affected 

as well as specific clinical, medical, 

public health, behavioral health, human 

services, employment, data science, and 

research expertise. The membership of 

the Committee will reflect diverse 

individuals or organizations including 

underserved populations, with a focus 

on health equity. 

The following areas of expertise will 

be considered in selecting the voting 

members with the goal of achieving a 

balanced membership in terms of points 

of view, expertise, and groups 

represented and functions to be 

performed by the Committee. 

Long COVID and related groups: 

Representation from individuals living 

with Long COVID and organizations 

directly engaged in supporting people 

living with Long COVID. 

Professional Associations: 

Representation from medical 

professional, behavioral health and 

human services associations 

representing practitioners caring for 

people with Long COVID, including 

those representing the primary 

healthcare system. 

Disability and Chronic Illness Groups: 

Representation from associations, 

researchers, or organizations focused on 

disability and chronic illness, and their 

possible interplay with Long COVID. 

Public Health and related groups: 

Representation from public health 

groups supporting communities in 

addressing the impacts of Long COVID. 

Healthcare and Social Care Providers: 

Clinical care settings and health systems 

involved in providing care for patients 

with Long COVID, including in 

underserved areas, such as rural 

communities and communities 

disproportionately impacted by Long 

COVID. 

Employee and Employer Related 

Groups: Representation from employee 

and employer experts, attorneys, or 

organizations involved in addressing the 

impacts of Long COVID in the 

workplace, including discrimination. 

Research: Researchers and research 

institutions involved in Long COVID 

and associated conditions research. 

Non-voting Industry Representatives: 

Those involved in, or representing those 

involved in, Long COVID research and 

development, including prevention, 

diagnostics, and treatment will be 

designated to represent the interests of 

this sector. 


khammond on DSKJM1Z7X2PROD with NOTICES

I I 
80320 Federal Register / Vol. 88, No. 221 / Friday, November 17, 2023 / Notices 

Non-voting Federal Liaisons, without 

limit, may be solicited, as needed, as ex 

officio members. 

Equal opportunity practices regarding 

membership appointments to the 

Committee will be aligned with HHS 

policies. To the extent possible, HHS 

will ensure the Committee membership 

is balanced in expertise, experience, 

education, and institutional affiliation. 

Members of the Committee will be 

classified as Special Government 

Employees (SGE) during their term of 

appointment and, as such, are subject to 

the ethical standards of conduct for 

federal employees. Upon entering the 

position and annually throughout the 

term of appointment, members of the 

Committee will be required to complete 

and submit a report of their financial 

holdings. 

Nominations and Appointments for 

Memberships: Nominees, including selfnominees, will be considered for 

appointment as members of the 

Committee. Only complete nomination 

packages submitted on time will be 

considered. To be considered for an 

appointment, submission of the 

following information for each nominee 

is required: (1) a cover letter that clearly 

states the name and place of work of the 

nominee, the rationale for the 

nomination, and a statement that the 

nominee would be willing to serve as a 

member of the Committee, if selected; 

(2) the name, address, telephone 

number, and email address for the 

individual being nominated and the 

nominator, if applicable; and (3) a copy 

of the nominee’s resume or curriculum 

vitae. Nominees with no professional 

affiliation may submit an optional letter 

of recommendation. 

The curriculum vitae should include 

the following information: (a) education; 

(b) experience (current and former); (c) 

affiliations; (d) current memberships 

(expert panels, committees, or other 

relevant groups, including positions 

held); (e) any peer-reviewed 

publications (for past 5 years); (f) any 

oral presentations (for past 5 years); (g) 

editorials, opinion pieces, and blogs (for 

past 5 years); (h) grants, contracts, or 

research funding (for past 15 years); (i) 

name of any corporation, professional 

society, association, panel, company, 

firm, government agency (Federal, State, 

and local), research organization, 

educational institution, committee, or 

other organization or institution 

(government, private, and not-for-profit; 

domestic and foreign) in which the 

nominee’s services have been, will be, 

or are expected to be provided, with or 

without compensation, including on a 

part-time or seasonal basis as an officer, 

medical staff, board member, owner, 

trustee, director, expert advisor, 

consultant (paid or unpaid), official 

spokesperson, member of speakers 

bureau, or expert witness (for past 5 

years and upcoming); (j) other paid 

travel or honoraria received, not 

included above (for past 5 years). If the 

nominee does not have anything to 

report for the sections, indicate ‘‘none.’’ 

Web links to publications, 

presentations, and other materials 

available online are requested, when 

available. 

Where prohibited by Federal law or 

regulations, nominations will not be 

accepted directly from HHS research 

and promotion boards. Self-nominations 

and nominations by members of 

research and promotion boards in their 

individual capacity will be considered. 

Federal employees should not be 

nominated for consideration for 

appointment to this Committee. 

Dated: November 2, 2023. 

Xavier Becerra, 

Secretary, Department of Health and Human 

Services. 

[FR Doc. 2023–24586 Filed 11–16–23; 8:45 am] 

BILLING CODE 4150–03–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Neurological 

Disorders and Stroke; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the National Institute of 

Neurological Disorders and Stroke 

Special Emphasis Panel, November 27, 

2023, 09:00 a.m. to November 29, 2023, 

06:00 p.m., Crowne Plaza National 

Airport, 1480 Crystal Drive, Arlington, 

VA 22202 which was published in the 

Federal Register on September 25, 2023, 

88 FR 67334. 

This notice is being amended to 

change the location to Canopy by 

Hilton, 940 Rose Avenue, North 

Bethesda, MD 20852, and change the 

meeting times to 10:00 a.m. to 6:00 p.m. 

The meeting dates remains the same. 

The meeting is closed to the public. 

Dated: November 13, 2023. 

David W. Freeman, 

Supervisory Program Analyst, Office of 

Federal Advisory Committee Policy. 

[FR Doc. 2023–25403 Filed 11–16–23; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Office of the Director, National 

Institutes of Health; Amended Notice 

of Meeting 

Notice is hereby given of an amended 

meeting notice of the Advisory 

Committee to the Director, National 

Institutes of Health, December 14–15, 

2023, open meeting that was published 

in the Federal Register on November 13, 

2023, 88 FR 77595. 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of a 

meeting of the Advisory Committee to 

the Director, National Institutes of 

Health. 

This will be a hybrid meeting held inperson and virtually and will be open to 

the public as indicated below. Members 

of the public are encouraged to attend 

virtually as space is limited. 

Individuals who plan to attend as 

well as those who need special 

assistance or other reasonable 

accommodations, should notify the 

Contact Person listed below in advance 

of the meeting. The meeting can be 

accessed from the NIH Videocast at the 

following link: https://

videocast.nih.gov/ as space is limited. 

Name of Committee: Advisory Committee 

to the Director, National Institutes of Health. 

Date: December 14, 2023. 

Time: 9:00 a.m. to 4:45 p.m. 

Agenda: NIH Director’s Report; NIH Public 

Access Plan; Cancer Moonshot; Addressing 

the Mental Health Crisis through Research; 

Assessing the Public Health Threat of PostAcute Sequelae of SARS CoV–2 Infection 

(PASC)—NIH RECOVER Initiative: Briefing 

for the Advisory Committee to the Director 

(ACD); The Foundation for the National 

Institutes of Health (FNIH); Other Business of 

the Committee. 

Date: December 15, 2023. 

Time: 9:00 a.m. to 2:45 p.m. 

Agenda: HeLa Genome Data Access 

Working Group: Data Access Requests; NIHWide Collaborative Initiative on Climate 

Change and Health; Clinical Trial 

Stewardship; Accessibility Update; Update 

from the ACD Working Group on Catalyzing 

the Development and Use of Novel 

Alternative Methods to Advance Biomedical 

Research; Update from the ACD Working 

Group on Re-envisioning NIH-Supported 

Postdoctoral Training; Other Business of the 

Committee. 

Place: National Institutes of Health, 

Building 1, Wilson Hall, One Center Drive, 

Bethesda, MD 20892. 

Contact Person: Cyndi Burrus-Shaw, Staff 

Assistant, National Institutes of Health, 

Office of the Director, One Center Drive, 

Building 1, Room 126, Bethesda, MD 20892, 

301–496–2433, shawcy@od.nih.gov 


khammond on DSKJM1Z7X2PROD with NOTICES